Related content

A patient with hyper-IgD syndrome in Antalya, Turkey

By Çoban Erkan   Terzioğlu Ender  

Clinical Rheumatology, Vol. 23, Iss. 2, 2004-04 ,pp. : 177-178

Springer Publishing Company

Access to resources Recommend Favorite

“Hyper-IgD syndrome” or “mevalonate kinase deficiency”: an old syndrome needing a new name?

By Celsi Fulvio   Tommasini Alberto   Crovella Sergio  

Rheumatology International, Vol. 34, Iss. 3, 2014-03 ,pp. : 423-424

Springer Publishing Company

Access to resources Recommend Favorite

Diagnostic challenge of hyper-IgD syndrome in four children with inflammatory gastrointestinal complaints

By Oretti Chiara   Barbi Egidio   Marchetti Federico   Lepore Loredana   Ventura Alessandro   D'Osualdo Andrea   Gattorno Marco   Martelossi Stefano   Tommasini Alberto  

Scandinavian Journal of Gastroenterology, Vol. 41, Iss. 4, 2006-03 ,pp. : 430-436

Informa Healthcare

Access to resources Recommend Favorite

Cerebral tuberculoma in a patient receiving anti-TNF alpha (adalimumab) treatment

By Lynch Karen   Farrell Michael  

Clinical Rheumatology, Vol. 29, Iss. 10, 2010-10 ,pp. : 1201-1204

Springer Publishing Company

Access to resources Recommend Favorite

Anti-TNF therapy in the treatment of ankylosing spondylitis: the Finnish experience

By Konttinen Liisa   Tuompo Riitta   Uusitalo Tea   Luosujärvi Riitta   Laiho Kari   Lähteenmäki Jukka   Puurtinen-Vilkki Maija   Lanteri Ritva   Kortelainen Saara   Karilainen Helena   Varjolahti-Lehtinen Tuire   Nordström Dan  

Clinical Rheumatology, Vol. 26, Iss. 10, 2007-10 ,pp. : 1693-1700

Springer Publishing Company

Access to resources Recommend Favorite